JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Earning before tax | ---- | 80.10%-193.53M | -257.69%-1.83B | ---- | -236.27%-972.54M | 129.10%1.16B | --713.66M | 85.38%506.72M | --273.34M |
Profit adjustment | |||||||||
Interest (income) - adjustment | ---- | 0.11%-12.27M | -109.51%-31.34M | ---- | -99.51%-12.29M | -283.78%-14.96M | ---6.16M | -50.00%-3.9M | ---2.6M |
Attributable subsidiary (profit) loss | ---- | 347.01%11.88M | 239.08%23.58M | ---- | 84.64%2.66M | -6,177.42%-16.96M | --1.44M | --279K | ---- |
Impairment and provisions: | ---- | -65.70%64.29M | 276.16%646.29M | ---- | 303.51%187.4M | 577.48%171.81M | --46.44M | 634.86%25.36M | --3.45M |
-Impairmen of inventory (reversal) | ---- | -68.74%69.49M | 664.19%554.55M | ---- | 11,351.37%222.33M | 3,159.97%72.57M | ---1.98M | -2.96%2.23M | --2.29M |
-Impairment of trade receivables (reversal) | ---- | 17.36%-31.79M | -93.89%4.19M | ---- | -180.76%-38.46M | 268.70%68.5M | --47.63M | 1,968.82%18.58M | --898K |
-Impairment of goodwill | ---- | 1,695.80%25.25M | 151.98%72.77M | ---- | --1.41M | --28.88M | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -37.58%1.33M | 692.81%14.78M | ---- | 168.47%2.13M | -59.09%1.86M | --793K | 1,659.07%4.56M | --259K |
Revaluation surplus: | ---- | 129.81%21.89M | 464.38%59.35M | ---- | 364.64%9.53M | -94.16%-16.29M | ---3.6M | -70.44%-8.39M | ---4.92M |
-Other fair value changes | ---- | 129.81%21.89M | 464.38%59.35M | ---- | 364.64%9.53M | -94.16%-16.29M | ---3.6M | -70.44%-8.39M | ---4.92M |
Asset sale loss (gain): | ---- | 102.52%388K | -5,827.11%-15.64M | ---- | -4,686.61%-15.41M | -86.98%273K | --336K | 84.67%2.1M | --1.14M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---16.58M | ---- | ---16.58M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -66.89%388K | 247.25%948K | ---- | 248.81%1.17M | -86.98%273K | --336K | 84.67%2.1M | --1.14M |
Depreciation and amortization: | ---- | 47.70%304.84M | 55.97%453.02M | ---- | 51.20%206.38M | 155.68%290.46M | --136.5M | 92.32%113.6M | --59.07M |
-Amortization of intangible assets | ---- | 98.36%13.15M | 227.08%20M | ---- | 247.30%6.63M | 48.64%6.12M | --1.91M | 50.20%4.11M | --2.74M |
Financial expense | ---- | 20.23%130.4M | 29.30%261.38M | ---- | 28.09%108.46M | 306.26%202.14M | --84.67M | 478.30%49.76M | --8.6M |
Special items | ---- | -77.99%2.84M | 127.80%2.68M | ---- | 2,107.31%12.91M | ---9.65M | ---643K | ---- | --7.89M |
Operating profit before the change of operating capital | ---- | 169.93%330.71M | -124.40%-431.24M | ---- | -148.62%-472.91M | 157.86%1.77B | --972.65M | 98.15%685.53M | --345.97M |
Change of operating capital | |||||||||
Inventory (increase) decrease | ---- | 35.77%-107.34M | 142.60%843.12M | ---- | 81.94%-167.13M | -234.14%-1.98B | ---925.64M | -1,165.20%-592.35M | ---46.82M |
Accounts receivable (increase)decrease | ---- | -41.20%240.35M | 131.92%787.81M | ---- | 127.68%408.79M | -1,649.16%-2.47B | ---1.48B | -112.13%-141.11M | ---66.52M |
Accounts payable increase (decrease) | ---- | -4,073.24%-423.21M | 8.48%656.04M | ---- | -101.43%-10.14M | 180.39%604.78M | --707.59M | -828.15%-752.31M | ---81.05M |
Special items for working capital changes | ---- | 140.04%47.03M | -196.70%-349.3M | ---- | -191.28%-117.45M | 1,386.57%361.21M | --128.66M | -16.16%24.3M | --28.98M |
Cash from business operations | ---- | 124.40%87.54M | 187.90%1.51B | ---- | 39.57%-358.84M | -120.87%-1.71B | ---593.82M | -529.76%-775.94M | --180.55M |
Other taxs | ---- | 80.03%-16.14M | 34.39%-98.2M | ---- | -3.13%-80.84M | -212.42%-149.67M | ---78.39M | -46.00%-47.91M | ---32.81M |
Adjustment items of business operations | 123.10%107.41M | ---- | ---- | ---464.95M | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 123.10%107.41M | 116.24%71.4M | 175.57%1.41B | ---464.95M | 34.59%-439.69M | -126.19%-1.86B | ---672.21M | -657.64%-823.85M | --147.74M |
Cash flow from investment activities | |||||||||
Interest received - investment | ---- | -0.11%12.27M | 109.51%31.34M | ---- | 99.51%12.29M | 283.78%14.96M | --6.16M | 50.00%3.9M | --2.6M |
Dividend received - investment | -56.05%18.6M | ---- | ---- | --42.33M | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | 278.17%263.11M | 131.11%149.58M | ---- | 13.69%-147.67M | -12,779.96%-480.81M | ---171.1M | 61.81%-3.73M | ---9.77M |
Sale of fixed assets | 328.62%513.92K | 11.51%1.06M | 2,850.59%380.21M | --119.9K | --947K | -32.29%12.89M | ---- | 2,374.77%19.03M | --769K |
Purchase of fixed assets | 69.53%-460.25M | 59.16%-558.59M | -42.49%-3.17B | ---1.51B | -143.62%-1.37B | -237.87%-2.22B | ---561.45M | -335.51%-657.79M | ---151.04M |
Purchase of intangible assets | ---- | 89.80%-3.89M | -284.15%-43.17M | ---- | -479.44%-38.14M | -35.15%-11.24M | ---6.58M | -178.56%-8.32M | ---2.99M |
Sale of subsidiaries | ---- | ---- | --38.19M | ---- | --38.19M | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 138.83%104.65M | ---40M | ---269.48M | ---- |
Recovery of cash from investments | -73.11%6.19M | -8.01%4.83B | 125.65%11.72B | --23M | 377.09%5.25B | 145.59%5.19B | --1.1B | 19.57%2.12B | --1.77B |
Cash on investment | ---- | 17.01%-5.61B | -125.64%-11.75B | ---49M | -395.21%-6.76B | -156.94%-5.21B | ---1.37B | -9.93%-2.03B | ---1.84B |
Other items in the investment business | 23.54%-903.29M | ---- | ---- | ---1.18B | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 49.98%-1.34B | 64.46%-1.07B | -1.75%-2.64B | ---2.68B | -190.59%-3.02B | -213.37%-2.6B | ---1.04B | -251.76%-828.43M | ---235.51M |
Net cash before financing | 60.81%-1.23B | 71.04%-1B | 72.35%-1.23B | ---3.14B | -102.14%-3.46B | -169.90%-4.46B | ---1.71B | -1,782.51%-1.65B | ---87.77M |
Cash flow from financing activities | |||||||||
New borrowing | -38.67%5.06B | -49.82%3.62B | 81.07%9.89B | --8.25B | 197.89%7.22B | 178.71%5.46B | --2.42B | 329.87%1.96B | --456M |
Refund | -21.23%-5.19B | -5.98%-3.47B | -237.00%-6.7B | ---4.28B | -290.61%-3.28B | -239.57%-1.99B | ---839.33M | -77.99%-585.6M | ---329M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --2.18B | --2.18B | ---- | --392.56M |
Interest paid - financing | ---- | -10.95%-113.6M | -84.70%-219.08M | ---- | -91.53%-102.39M | -187.80%-118.62M | ---53.46M | -405.77%-41.22M | ---8.15M |
Dividends paid - financing | -14.30%-188.66M | 25.19%-4.27M | 95.58%-5.71M | ---165.05M | 45.16%-5.71M | -77.81%-129.3M | ---10.42M | -43.15%-72.72M | ---50.8M |
Absorb investment income | 383.32%478.49M | 10.79%93.06M | --129M | --99M | --84M | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | -219.01%-38.28M | ---- | ---38.28M | -13,231.11%-12M | ---- | 97.32%-90K | ---3.36M |
Other items of the financing business | -95.90%-291.43M | --385.43M | ---- | ---148.77M | ---- | ---- | ---- | --345M | ---- |
Net cash from financing operations | -103.48%-130.65M | -91.12%330.19M | -48.60%2.65B | --3.76B | 0.96%3.72B | 223.79%5.15B | --3.68B | 248.17%1.59B | --457.26M |
Effect of rate | -133.41%-1.87M | -142.14%-1.08M | 1,125.81%12.87M | --5.6M | 966.39%2.57M | 844.68%1.05M | --241K | -34.29%-141K | ---105K |
Net Cash | -320.74%-1.36B | -357.57%-671.58M | 103.74%1.42B | --616.78M | -86.79%260.74M | 1,253.71%695.19M | --1.97B | -116.31%-60.26M | --369.49M |
Begining period cash | 93.45%2.96B | 93.45%2.96B | 83.57%1.53B | --1.53B | 83.57%1.53B | -6.76%833.13M | --833.13M | 70.47%893.53M | --524.15M |
Cash at the end | -25.86%1.6B | 27.52%2.29B | 93.45%2.96B | --2.15B | -36.13%1.79B | 83.57%1.53B | --2.81B | -6.76%833.13M | --893.53M |
Cash balance analysis | |||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | IAS | CAS (2007) | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.